Rapid scan techniques have introduced new sequence parameters as well as novel contrast concepts into everyday magnetic resonance imaging (MRI). In particular contrast characteristics of fast-spin echo (FSE) sequences showed some significant differences when compared to conventional spin echo images. The purpose of this work was to demonstrate the capabilities of FSE MRI in identifying and characterizing the in vivo anatomy of the main cerebral associative systems. Between March and November 1995, 20 healthy adult volunteers (12 males, 8 females, mean age 35 years) were submitted to a cranial MRI examination (1.5 Philips Gyroscan NT). In all cases axial and coronal 2-dimensional FSE T2-weighted and 2-dimensional inversion recovery FSE T1-weighted images were obtained. All MRI images were examined by a neuroradiologist (G. Dal Pozzo) for the depiction of the following compact white matter fiber bundles: anterior commissure, corpus callosum, superior fronto-occipital fasciculus, cingulum, fornix, mammillothalamic tract, uncinate fasciculus, superior and inferior longitudinal fasciculus. All these associative pathways could be well identified on T2-weighted images due to a lower signal intensity with respect to the surrounding white matter. On T1-weighted images only the corpus callosum, the anterior commissure and the fornix could always be identified. Correlation with myelin-specific colorations (Luxol fast blue stains) in anatomic atlases and a review of the literature on the myelinization process during infancy indicate that the short T2 relaxation times of the aforementioned cerebral associative systems may be due to heavy myelination and high fiber density. The correct visualization of interintrahemispheric associative white matter fiber bundles may play an important role in white matter disorders like dys- and demyelinating diseases and in the spreading of vasogenic edema and/or tumor being useful for their staging.

Keywords:
Brain anatomy, White matter, Magnetic resonance imaging
This content is only available via PDF.
© 1997 S. Karger AG, Basel
1997
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.